SCHEMBL689761

SCHEMBL689761

CCCCCO[SiH2]c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.47
CYP3A4 P08684 3/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
TP53 P04637 1/20 0.42
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
PTPN1 P18031 1/20 0.38
NR1I2 O75469 2/20 0.38
CHRM2 P08172 2/20 0.38
ADRA2A P08913 2/20 0.38
OPRK1 P41145 2/20 0.38
HTR2B P41595 2/20 0.38
SLC6A3 Q01959 2/20 0.38
MLNR O43193 1/20 0.38
ESR1 P03372 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL706853 0.94 LTA4H (0.47) LTA4HCYP3A4TSHRMAPK1TP53
SCHEMBL703559 0.85 LMNA (0.39) LTA4HMAPK1TP53LMNAALDH1A1
SCHEMBL27285938 0.82 TSHR (0.40) LTA4HCYP3A4TSHRMAPK1TP53
SCHEMBL28446962 0.81 SMN1; SMN2 (0.39) TSHRMAPK1TP53ALDH1A1HTT
SCHEMBL28015828 0.80 CYP1A2 (0.50) LTA4HCYP3A4LMNANR1I2CHRM2
SCHEMBL3295135 0.80 MAPK1 (0.39) MAPK1LMNAALDH1A1SMN1; SMN2MEN1
SCHEMBL5049322 0.79 LTA4H (0.42) LTA4HCYP3A4TSHRMAPK1ALDH1A1
SCHEMBL3293621 0.78 SMN1; SMN2 (0.35) TSHRMAPK1LMNAALDH1A1CHRM3
SCHEMBL27852600 0.76 MEN1 (0.36) LMNAALDH1A1KCNA3HTTMEN1
SCHEMBL27639890 0.76 L3MBTL1 (0.40) LTA4HCYP3A4TSHRMAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4244232-A1 OLIGONUCLEOTIDES, REAGENTS AND PREPARATION THEREOF Biogen MA Inc. (US) 2023-09-20 EP claimed
WO-2022103842-A1 OLIGONUCLEOTIDES, REAGENTS AND PREPARATION THEREOF BIOGEN MA INC. (US) 2022-05-19 WO claimed
WO-2013102793-A2 A NOVEL PROCESS FOR THE PREPARATION OF REBAUDIOSIDE D AND OTHER RELATED NATURALLY OCCURRING SWEETENERS SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-07-11 WO claimed
WO-2012075277-A2 SYNTHETIC METHODS NOVOMER, INC. (US) 2012-06-07 WO claimed
EP-2037762-A4 METHOD TO PREPARE PURE CURCUMIN KIM DARRICK S H L (US) 2009-07-08 EP claimed
EP-2037762-A1 METHOD TO PREPARE PURE CURCUMIN Kim, Darrick S.H.L. (US) 2009-03-25 EP claimed
WO-2009013764-A2 PROCESS FOR PRODUCING 6(R)-[2-(8'(S)-2 ',2 '-DIMETHYLBUTYRYLOXY-2'(S),6'(R)-DIMETHYL-1,2,6,7', 8',8A'(R)- HEXAHYDRONAPHTHYL-L'(S))ETHYL]-4(R)-HYDROXY-3,4,5,6- TETRAHYDRO-2H-PYRAN-2-ONE JUBILANT ORGANOSYS LIMITED (IN) 2009-01-29 WO claimed
WO-2007143635-A1 METHOD TO PREPARE PURE CURCUMIN KIM DARRICK S (US) 2007-12-13 WO claimed
EP-4396354-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2024-07-10 EP disclosed
WO-2024145281-A1 BIODEGRADABLE LIPIDS AND FORMULATIONS FOR INTRAMUSCULAR, IN VITRO, AND EX VIVO TRANSFECTION OF MRNA MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-07-04 WO disclosed
WO-2024145435-A2 LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS Life Technologies Corporation (US) 2024-07-04 WO disclosed
WO-2024086717-A2 HETEROARYL ENHANCERS OF THE PARTICULATE GUANYLYL CYCLASE RECEPTOR A UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-04-25 WO disclosed
EP-4340859-A1 ANTIBODY DRUG CONJUGATES USING MATES TECHNOLOGY FOR DELIVERING CYTOTOXIC AGENTS Biohaven Therapeutics Ltd. (US) 2024-03-27 EP disclosed
WO-2024054669-A2 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF NUCLEIC ACID-BASED THERAPEUTICS AND METHODS THEREOF NANOTECH PHARMA INC. (US) 2024-03-14 WO disclosed
WO-1998008382-A1 NONCLASSICAL PYRROLO[2,3-D]PYRIMIDINE ANTIFOLATES ELI LILLY AND COMPANY (US) 1998-03-05 WO disclosed
EP-0759917-A1 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES GILEAD SCIENCES, INC. (US) 1997-03-05 EP disclosed
EP-0743952-A1 GENERATION AND SCREENING OF SYNTHETIC DRUG LIBRARIES MARTEK BIOSCIENCES CORPORATION (US) 1996-11-27 EP disclosed
WO-1995021850-A1 GENERATION AND SCREENING OF SYNTHETIC DRUG LIBRARIES MARTEK BIOSCIENCES CORPORATION (US) 1995-08-17 WO disclosed
WO-1995021841-A1 1-β-METHYL-CARBAPENEM, COMPOSITIONS CONTAINING SAME AND METHODS OF USE MERCK & CO., INC. (US) 1995-08-17 WO disclosed
EP-0541042-A1 2,4- and 2,5-pyridine-dicarboxylic acid derivatives, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1993-05-12 EP disclosed